Komori
Medical System Network (4350) · RiskRestated

Risk of Changes to Systems and Business Models Resulting from Changes in Pharmaceutical Distribution Regulations

First written in FY2016. 3 of 4 entries say "Restated". Latest entry: FY2022.

4entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20222016: 120162017: 120172018: 020182019: 020192020: 020202021: 120212022: 12022
Same theme, other companies

The whole theme swung hardest in 2020: 1 of 9 companies on the "Worse" side.

11 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「If changes to rules and other requirements related to pharmaceutical distribution result in a fundamental change to the current pharmaceutical distribution system, creating a situation that the Group's systems cannot accommodate, the business model of these operations may be affected.」

    The risk of changes to pharmaceutical distribution rules affecting the system and business model continues.
  2. FY2021RestatedAnnual report

    「If changes to rules and other requirements related to pharmaceutical distribution result in a fundamental change to the current pharmaceutical distribution system, creating a situation that the Group's systems cannot accommodate, the business model of these operations may be affected.」

    The risk of changes to pharmaceutical distribution rules affecting the system and business model continues to be disclosed.
  3. FY2017RestatedAnnual report

    「If changes to rules and other requirements related to pharmaceutical distribution result in a fundamental change to the current pharmaceutical distribution system, creating a situation that the Group's systems cannot accommodate, the business model of these operations may be affected.」

    The risk of changes to pharmaceutical distribution rules affecting the system and business model continues to be disclosed.
  4. FY2016First statedAnnual report

    「If changes to rules and other requirements related to pharmaceutical distribution result in a fundamental change to the current pharmaceutical distribution system, creating a situation that the Group's systems cannot accommodate, the business model of these operations may be affected.」

    The ability to respond to regulatory and institutional changes affecting the order-processing network is identified as a risk.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Medical System Network's next results are scheduled for 2026-11-10. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.